Figure 2.1.1
C2.1F1 Genetic predictors for placebo effects.

C2.1F1 Genetic predictors for placebo effects.

(A) IBS outcomes (IBS-SSS) by COMT genotype and varying placebo treatments.65 (B) Major cardiovascular disease outcomes by COMT genotype in the WHS.62 (C) Placebo and aspirin response in cardiovascular disease prevention by COMT genotype in the WHS. (D) Placebo and vitamin E response in cardiovascular disease prevention by COMT genotype in the WHS.62

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close